InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
5
T+90 hit rate
100%
T+90 mean return
+8.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Fromkin Andrew J., Director. Insider active across 1 company, notably Immunovant, Inc.. Aggregated, 16 reports have been published. Split: 1 buy · 5 sells. Total volume traded: €7.1m. History available since 10 August 2021. The latest transaction was disclosed on 28 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Fromkin Andrew J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
31,668 shares@ US$4.990.0024% mcap1.5% of flowCommon StockSEC:0001341896-26-000004:0
71,492 shares@ US$7.940.0087% mcap5.5% of flowCommon StockSEC:0001341896-26-000004:1
77,181 shares@ US$8.430.010% mcap6.3% of flowCommon StockSEC:0001341896-26-000004:2
16,260 shares@ US$14.700.0037% mcap2.3% of flowCommon StockSEC:0001341896-26-000004:3
11,483 shares@ US$32.640.0058% mcap3.6% of flowCommon StockSEC:0001341896-26-000004:4
210,468 shares@ US$33.560.11% mcap68.3% of flowCommon StockSEC:0001341896-26-000004:5
13,880 shares0Common StockSEC:0001764013-26-000050:0
19,351 shares@ US$23.140.0069% mcap45.6% of flowCommon StockSEC:0001764013-25-000160:0
16,188 shares0Common StockSEC:0001764013-25-000043:0
6,616 shares@ US$19.521.3% of flowCommon StockSEC:0001764013-25-000034:0
11,255 shares0Common StockSEC:0001764013-24-000067:0
3,941 shares@ US$38.781.6% of flowCommon StockSEC:0001764013-23-000156:0
12,523 shares0Common StockSEC:0001764013-23-000045:0
21,059 shares0Common StockSEC:0001764013-22-000097:0
21,726 shares0Common StockSEC:0001764013-22-000021:0
5,500 shares@ US$7.900.4% of flowCommon StockSEC:0001764013-21-000081:0
Canonical exit: 8 Nov 2021 (T+90)
16 of 16 declarations
About Fromkin Andrew J.
Andrew J. Fromkin is a Director at Immunovant, Inc. As a board member, he contributes to the governance of the company, providing his expertise and strategic advice. His role is essential in guiding Immunovant's decisions and initiatives.
